Outcome after cardiopulmonary resuscitation in patients with congenital heart disease

Similar documents
When to implant an ICD in systemic right ventricle?

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.

Tetralogy of Fallot Latest data in risk stratification and replacement of pulmonic valve

Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition

The ARREST Trial: Amiodarone for Resuscitation After Out-of-Hospital Cardiac Arrest Due to Ventricular Fibrillation

Key statistics from the National Cardiac Arrest Audit: Paediatric arrests April 2012 to March 2017

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

ECG Changes in Patients Treated with Mild Hypothermia after Cardio-pulmonary Resuscitation for Out-of-hospital Cardiac Arrest

Failure of epicardial pacing leads in congenital heart disease: not uncommon and difficult to predict

Index. Note: Page numbers of article titles are in boldface type.

PROBLEM: Shock refractory VF/pVT BACKGROUND: Both in 2015 CoSTR. Amiodarone favoured.

Out-of-hospital Cardiac Arrest. Franz R. Eberli MD, FESC, FAHA Cardiology Triemli Hospital Zurich, Switzerland

Dear Parent/Guardian,

Update on Sudden Cardiac Death and Resuscitation

Supplementary Online Content

Epinephrine Cardiovascular Emergencies Symposium 2018

Shuichi Shiraishi, Masashi Takahashi, Ai Sugimoto, Masanori Tsuchida. Introduction

Outcomes of Therapeutic Hypothermia in Cardiac Arrest. Saad Mohammed Shariff, MBBS Aravind Herle, MD, FACC

Changing Profile of Adult Congenital Heart Disease

Sudden cardiac death in adults with congenital heart disease: does QRS-complex fragmentation discriminate in structurally abnormal hearts?

But unfortunately, the first sign of cardiovascular disease is often the last. Chest-Compression-Only Resuscitation Gordon A.

Lesson learnt from big trials. Sung Phil Chung, MD Gangnam Severance Hospital, Yonsei Univ.

Congenital heart disease (CHD) is

CPR What Works, What Doesn t

September 26, 2012 Philip Stockwell, MD Lifespan CVI Assistant Professor of Medicine (Clinical)

The incidence and risk factors of arrhythmias in the early period after cardiac surgery in pediatric patients

Department of Surgery, Division of Cardiothoracic Surgery

Management of Cardiac Arrest Based on : 2010 American Heart Association Guidelines

ICD THERAPIES: are they harmful or just high risk markers?

Kiehl EL, 1,2 Parker AM, 1 Matar RM, 2 Gottbrecht M, 1 Johansen MC, 1 Adams MP, 1 Griffiths LA, 2 Bidwell KL, 1 Menon V, 2 Enfield KB, 1 Gimple LW 1

Stayin Alive: Pediatric Advanced Life Support (PALS) Updated Guidelines

ACLS Prep. Preparation is key to a successful ACLS experience. Please complete the ACLS Pretest and Please complete this ACLS Prep.

Mitral Valve Disease, When to Intervene

Overview and Latest Research on Out of Hospital Cardiac Arrest

Hanna K. Al-Makhamreh, M.D., FACC Interventional Cardiologist

Management of Heart Failure in Adult with Congenital Heart Disease

Adult Echocardiography Examination Content Outline

Behavior of Ebstein s Anomaly: Single-Center Experience and Midterm Follow-Up

SUDDEN DEATH IN CHILDREN AND ADOLESCENTS

Arrhythmias and congenital heart disease

Update on Sudden Cardiac Death and Resuscitation

2015 AHA Guidelines: Pediatric Updates

Arrhythmias in Adult Congenital Heart Disease

WORKSHEET for Evidence-Based Review of Science for Veterinary CPCR

Appearance of QRS fragmentation late after Mustard/ Senning repair is associated with adverse outcome

MEDICAL SCIENCES Vol.I -Adult Congenital Heart Disease: A Challenging Population - Khalid Aly Sorour

Disclosures. Overview. Cardiopulmonary Arrest: Quality Measures 5/29/2014. In-Hospital Cardiac Arrest: Measuring Effectiveness and Improving Outcomes

Cardiac MRI in ACHD What We. ACHD Patients

Supplementary Appendix

The Therapeutic Role of the Implantable Cardioverter Defibrillator in Arrhythmogenic Right Ventricular Dysplasia

The Fetal Cardiology Program

Risky business: Insuring adults with congenital heart disease

Index. cardiacep.theclinics.com. Note: Page numbers of article titles are in boldface type.

Adults with Congenital Heart Disease. Michael E. McConnell MD, Wendy Book MD Teresa Lyle RN NNP

ARRHYTHMIAS AND DEVICE THERAPY

THE FOLLOWING QUESTIONS RELATE TO THE RESUSCITATION COUNCIL (UK) RESUSCITATION GUIDELINES 2005

ADULT CONGENITAL HEART DISEASE AN UPDATE FOR CARDIOLOGISTS AND PRIMARY CARE PHYSICIANS

Evaluation of the Right Ventricle and Risk Stratification for Sudden Cardiac Death

Clinicians and Facilities: RESOURCES WHEN CARING FOR WOMEN WITH ADULT CONGENITAL HEART DISEASE OR OTHER FORMS OF CARDIOVASCULAR DISEASE!!

Outline. Congenital Heart Disease. Special Considerations for Special Populations: Congenital Heart Disease

Heart and Soul Evaluation of the Fetal Heart

Sudden cardiac death: Primary and secondary prevention

ECLS: A new frontier for refractory V.Fib and pulseless VT

EP In Adults with Congenital Heart Disease

Cardiac Catheterization Cases Primary Cardiac Diagnoses Facility 12 month period from to PRIMARY DIAGNOSES (one per patient)

Echocardiography in Adult Congenital Heart Disease

Implantation of Cardioverter Defibrillator After Percutaneous Closure of Atrial Septal Defect

S. Bruce Greenberg, MD FNASCI and President, NASCI Professor of Radiology and Pediatrics University of Arkansas for Medical Sciences

3/14/2011 MANAGEMENT OF NEWBORNS CARDIAC INTENSIVE CARE CONFERENCE FOR HEALTH PROFESSIONALS IRVINE, CA. MARCH 7, 2011 WITH HEART DEFECTS

Common Defects With Expected Adult Survival:

Cardiopulmonary exercise test among children with congenital heart diseases: a multicenter study

Update of CPR AHA Guidelines

DIAGNOSIS, MANAGEMENT AND OUTCOME OF HEART DISEASE IN SUDANESE PATIENTS

In-hospital Care of the Post-Cardiac Arrest Patient. David A. Pearson, MD, FACEP, FAAEM Associate Program Director Department of Emergency Medicine

Pediatrics. Arrhythmias in Children: Bradycardia and Tachycardia Diagnosis and Treatment. Overview

had non-continuous enrolment in Medicare Part A or Part B during the year following initial admission;

Children with Single Ventricle Physiology: The Possibilities

DECLARATION OF CONFLICT OF INTEREST. Research grants: Sanofi-Aventis

Journal of the American College of Cardiology Vol. 37, No. 2, by the American College of Cardiology ISSN /01/$20.

Refractory cardiac arrest

Adults With Congenital Heart. Disease. An Expanding Population. In this article:

Since first successfully performed by Jatene et al, the

Anesthetic Considerations in Adults with Congenital Heart Disease

A Unique Milieu for Perioperative Care of Adult Congenital Heart Disease Patients at a Single Institution

Adult Congenital Heart Disease T S U N ` A M I!

Implantable cardioverter defibrillator therapy in grown-up patients with transposition of the great arteries role of anti-tachycardia pacing

cctga patients need lifelong follow-up in an age-appropriate facility with expertise in

ADVANCED LIFE SUPPORT

The modified natural history of congenital heart disease

Initial Rhythms and Outcomes for In-Hospital Cardiac Arrest in Kenya

(2013 ) ACHD ACHD

Are there low risk patients in Brugada syndrome?

Debate: Asymptomatic Patients with Ventricular Preexcitation Require EP Testing for Risk Stratification. Carlo Pappone, MD, PhD, FACC

Clinical Policy: Holter Monitors Reference Number: CP.MP.113

Introduction. Pediatric Cardiology. General Appearance. Tools of Assessment. Auscultation. Vital Signs

A Square Peg in a Round Hole: CRT IN PAEDIATRICS AND CONGENITAL HEART DISEASE

Chapter 19 Detection of ROSC in Patients with Cardiac Arrest During Chest Compression Using NIRS: A Pilot Study

Emergency Cardiac Care Guidelines 2015

Risk Stratification for Sudden Death in ACHD

Code Talkers NONE. Disclosures Brady & Slovis. Lay Provider Care. Cardiac Arrest 2017 Resuscitation & Post-arrest Management

Transcription:

697451ACC0010.1177/2048872617697451European Heart Journal: Acute Cardiovascular CareVan Puyvelde et al. research-article2017 Original scientific paper Outcome after cardiopulmonary resuscitation in patients with congenital heart disease EUROPEAN SOCIETY OF CARDIOLOGY European Heart Journal: Acute Cardiovascular Care 1 8 The European Society of Cardiology 2017 Reprints and permissions: sagepub.co.uk/journalspermissions.nav https://doi.org/10.1177/2048872617697451 DOI: journals.sagepub.com/home/acc Tim Van Puyvelde 1, Koen Ameloot 2, Mieke Roggen 3, Els Troost 4, Marc Gewillig 3, Werner Budts 4 and Alexander Van De Bruaene 4 Abstract Background: Outcome after cardiopulmonary resuscitation (CPR) in patients with underlying congenital heart disease is uncertain. This study aimed at evaluating outcome after CPR in patients with underlying congenital heart disease, factors related to worse outcome after CPR and whether survivors of sudden cardiac death (SCD) have a worse outcome when compared to an age, gender and disease-matched control population. Methods: Between 1984 and 2015, all patients with congenital heart disease who received in or out-of-hospital CPR were identified from the database of congenital heart disease from the University Hospitals Leuven. Postoperative and neonatal (<6 months of age) CPR was excluded. For each survivor of SCD, two control patients matched for gender, age and underlying heart defect were included in the study. Results: Thirty-eight patients (66% men; median age 25 years (interquartile range 9 40); 68% out-of-hospital) were identified, of which 27 (66%) survived the event. The main cause of SCD was ventricular tachycardia or fibrillation (n=21). Heart defect complexity (odds ratio (OR) 5.1; 95% confidence interval (CI) 1.2 21.9; P=0.027), pulmonary hypertension (OR 13.8; 95% CI 2.1 89.5; P=0.006) and time to return of spontaneous circulation (OR 1.1; 95% CI 1.0 1.1; P=0.046) were related to worse outcome. Survivors of SCD had a worse prognosis when compared to an age, gender and disease-matched control group (5-year survival 76% vs. 98%; P=0.002). Conclusions: The complexity of underlying heart defect, pulmonary hypertension and time to return of spontaneous circulation are related to worse outcome in the case of CPR. Survivors of SCD have a worse outcome when compared to matched controls, indicating the need for adequate implantable cardioverter defibrillator indication assessment and for stringent follow-up of patients with worsening haemodynamics. Keywords Congenital heart disease, cardiopulmonary resuscitation, sudden cardiac death, outcome Date received: 24 August 2016; accepted: 9 February 2017 Introduction The overall survival of patients with congenital heart disease has improved dramatically due to advances in cardiac surgery, intensive care and diagnostic capabilities, with 88% of children surviving into adulthood. 1 However, sudden cardiac death (SCD) remains an important concern in patients with congenital heart disease. Although the annual incidence of SCD in the congenital heart disease population is low (0.09% per year), it is higher when compared to agematched controls, 2 and constitutes an important cause of 1 Department of Internal Medicine, University Hospitals Leuven, Belgium 2 Department of Cardiology, University Hospitals Leuven, Belgium 3 Department of Pediatric Cardiology, University Hospitals Leuven, Belgium 4 Department of Congenital and Structural Cardiology, University Hospitals Leuven, Belgium Corresponding author: Alexander Van De Bruaene, Congenital and Structural Cardiology, University Hospitals Leuven, Herestraat 49, B-3000, Leuven, Belgium. Email: alexvandebruaene@hotmail.com

2 European Heart Journal: Acute Cardiovascular Care death in this patient population (approximately 20%). 2,3 Previous studies have identified risk factors for SCD for the adult congenital heart disease population, 2 or subpopulations such as patients with tetralogy of Fallot (ToF) 4,5 or transposition of the great arteries (TGA), 6 but there is little information on the outcome of cardiopulmonary resuscitation (CPR) in this group of patients. Even if CPR is initiated in the case of a cardiac arrest, outcome remains poor, with 17.6% of patients surviving in the case of inhospital cardiac arrest, 7 but only 7.6% in the case of out-of-hospital cardiac arrest (OHCA). 8 In non-congenital heart disease patients, it has been shown that longterm survival after OHCA is similar to age, gender and disease-matched patients. 9 Therefore, this study aimed at evaluating outcome after CPR in patients with underlying congenital heart disease, factors related to worse outcome after CPR, and outcome of survivors of SCD when compared to an age, gender and disease-matched control population. Methods Patient population This was a single-centre, retrospective study. All congenital heart disease patients who received in or out-of-hospital CPR between 1984 and 2015 were identified from the database of Congenital and Structural Cardiology at the University Hospitals Leuven. SCD was defined as sudden loss of consciousness with either documented underlying arrhythmic cause or loss of pulse without arrhythmia. Congenital heart disease was defined as a structural abnormality of the heart or intrathoracic great vessels with actual or potential functional significance. 1 Patients who were diagnosed with a cardiomyopathy or arrhythmia without structural abnormality were excluded from the analysis. Patients who received CPR in the neonatal period (before 6 months of age) or in the perioperative period of cardiac surgery were also excluded. The study complies with the Declaration of Helsinki and was approved by both the medical ethics committee of the University Hospitals Leuven and by the medical ethics committee of the University of Leuven. Data collection Demographic data, medical history (type of congenital heart defect, presence of pulmonary hypertension), firstrecorded cardiac rhythm at event, prehospital management and intensive care unit (ICU) admission were reviewed from the patients medical records. Date of death, reason of death and data of the last out or inpatient visit censored at 31 December 2015 were extracted from the database. Patients were classified according to the complexity of their underlying congenital heart defect into mild, moderate and severe congenital heart disease as outlined by Task Force 1 of the 32nd Bethesda Conference. 10 Early mortality was defined as any death occurring within the first 30 days after presentation or an inhospital death occurring more than 30 days after presentation but during the first admission. Late mortality was defined as any death occurring later than 30 days after presentation and occurring after the first hospital admission. For each included patient who survived until discharge, two controls without prior SCD were matched for age (plus or minus 5 years as compared to corresponding case), gender and underlying congenital heart defect. Controls were randomly selected from the database of Congenital and Structural Cardiology at the University Hospitals Leuven. Statistical analysis Data analyses were performed using SPSS software for Mac (22.0 for Mac; SPSS Inc., Chicago, IL, USA). For all analyses, a two-tailed P value less than 0.05 was considered statistically significant. Continuous variables are presented by means and standard deviations or, in the case of serious deviations from the normal assumption, by medians and ranges. Categorical variables are presented using observed frequencies and percentages relative to the total number of non-missing data points. When frequencies and means were compared across subgroups, one-way analysis of variance with Tukey s post-hoc test and Fisher s exact test were performed. To identify variables related to inhospital mortality, univariate binary logistic regression analysis was performed. No multivariate analysis was performed because of the small number of patients. Results were reported as odds ratios (ORs) with 95% confidence intervals (CIs). For each survivor of SCD, two control patients were identified and matched to: age (±5 years of age) at the time of the event; gender; and underlying heart defect. Controls were randomly selected in the database of Congenital and Structural Cardiology. Kaplan Meier analysis and log-rank testing was performed to compare the outcome of survivors of SCD with a matched control population. Results Patient selection The initial search of the database of Congenital and Structural Cardiology yielded a total of 113 patients. At initial review, 54 patients were excluded. Reasons for exclusion were a morphologically normal heart (n=35), cardiomyopathy without structural abnormality (n=12), presentation at less than 6 months of age (n=6) or a cardiac tumour without associated congenital heart disease (n=1). The patient files of the remaining 59 patients were reviewed and an additional 21 patients were excluded from further analysis because the event occurred in the perioperative period of cardiac surgery (n=18) or because the circumstances of the CPR were unclear (n=3). A total of 38 patients remained for final analysis. The study selection process is depicted in Figure 1.

Van Puyvelde et al. 3 Figure 1. Flow diaphragm depicting patient selection process. *Four patients with long QT-syndrome, one with Wolff Parkinson White syndrome and one with automated atrial ectopic tachycardia. CPR: cardiopulmonary resuscitation. Patient characteristics Overall, the median age at resuscitation was 25 years (interquartile range (IQR) 9 40). Twenty-five patients (66%) were men. Four patients (3%) had mild, 18 (48%) moderate and 16 (42%) severe complexity of the underlying congenital heart defect. The median age at resuscitation for each category of severity was 19 (IQR 5 37), 28 (IQR 8 44) and 25 (IQR 10 39) years, respectively. Eight patients (21%) had pulmonary hypertension. Echocardiographic data in the year before the event were available in 16 patients (42%). Five had moderately reduced systolic ventricular function and two had severely reduced systolic ventricular function. For two patients (5.3%), SCD was the first manifestation of their underlying congenital heart defect. Eleven patients (30%) presented with SCD between years 1984 and 2000 and 27 patients (70%) after year 2000. Patients with more severe congenital heart disease were more likely to have pulmonary hypertension (P=0.021). Additional demographic data stratified for the severity of underlying congenital heart disease are presented in Table 1. Event characteristics In 35 patients (92%) the cardiac arrest was considered to be of primary cardiac nature. In three patients requiring CPR, the immediate cause of arrest was non-cardiac. One occurred in the setting of a severe gastrointestinal bleed, one was related to hypoxia after aspiration and one occurred during an anaphylactic reaction. Rhythm documentation was available in 29 patients (76%) and showed ventricular fibrillation in 18 (62%), pulseless electrical activity in five (17%), ventricular tachycardia in three (10%), supraventricular tachycardia in two (7%) and asystole in one (3%) (Table 2). Twenty-one (68%) patients experienced an OHCA. Of those presenting with OHCA, 15 (71%) received bystander CPR and 18 (86%) received advanced life support. One patient did not receive any life support prehospital. The median time to return of spontaneous circulation (ROSC) was 23 minutes (IQR 15 34). This is longer, but not statistically different, from patients with inhospital cardiac arrest (median 10 minutes (IQR 4 41); P=0.330). Overall, 23 (79%) patients presented with a shockable rhythm, of which 13 (57%) received one or more direct current (DC) shocks. When applied, the median number of DC shocks was three (IQR 1 5). Fourteen patients (64%) were administered at least one shot of epinephrine and five patients (23%) received atropine. Twenty patients (69%) were admitted to the (cardiac) ICU. Twenty-two patients (79%) required intubation and mechanical ventilation. Two patients (7%) received extracorporeal membrane oxygenation. Twelve patients (44%) were transferred to our hospital from a secondary care centre for further management. There was no patient with significant coronary artery disease. Additional event characteristics stratified for the severity of congenital heart disease can be seen in Table 3. Outcome: early mortality Of 38 patients included, 25 patients (66%) survived until hospital discharge. Of those 25 patients, five patients died over a median follow-up time of 3 years (IQR 1 8). Outcome data were missing in two patients. Twelve patients

4 European Heart Journal: Acute Cardiovascular Care Table 1. Patient characteristics stratified to severity of congenital heart disease. Variable Total (n=38) Congenital heart disease severity P value Mild (n=4) Moderate (n=18) Severe (n=16) Median age, years (IQR) 25 (9 40) 19 (5 37) 28 (8 44) 25 (10 39) 0.904 Male gender, n (%) n=38 25 (66) 2/4 (50) 11/18 (61) 12/16 (75) 0.549 SCD before year 2000, n (%) n=37 11 (30) 1/4 (30) 5/17 (29) 5/16 (31) 1.000 Pulmonary hypertension 8 (21) 0/4 (0) 1/18 (6) 7/16 (44) 0.021 Underlying pathology, n (%) n=38 Eisenmenger syndrome 6 (16) Tetralogy of Fallot 8 (21) Left-sided outflow lesions 6 (16) Univentricular heart 4 (11) (cc) TGA 4 (11) Ebstein s anomaly 2 (5) Other a 2 (5) a Mitral valve dysplasia and cor triatrium. SCD: sudden cardiac death; (cc) TGA: congenitally corrected transposition of the great arteries. Table 2. Initial rhythm in relation to underlying pathology. Underlying pathology Initial rhythm VT (n=3) VF (n=18) PEA (n=5) Asystole (n=1) SVT (n=2) Eisenmenger syndrome 3 1 Tetralogy of Fallot 3 2 1 Left-sided outflow lesions 3 Univentricular heart 1 2 1 1 Septal lesions 2 3 1 (cc) TGA 1 1 Ebstein s anomaly 1 Other a 2 a Mitral valve dysplasia and cor triatrium. VT: ventricular tachycardia; VF: ventricular fibrillation; PEA: pulseless electrical activity; SVT: supraventricular tachycardia; SR: sinus rhythm; (cc) TGA: congenitally corrected transposition of the great arteries. received an implantable cardioverter defibrillator (ICD) after the event. The median age at ICD implantation was 38 years (IQR 18 44). Of 13 survivors who did not receive an ICD, seven had a reversible risk factor for cardiac arrest, two collapsed due to atrial arrhythmia, two patients had cardiac arrest in the early ICD era and for two patients the reason to withhold ICD were unclear from the charts. Univariate binary logistic regression analysis showed that the complexity of the underlying heart defect (OR 5.1; 95% CI 1.2 21.9; P=0.027), pulmonary hypertension (OR 13.8; 95% CI 2.1 89.5; P=0.006) and time to ROSC (OR 1.1; 95% CI 1.0 1.1; P=0.046) were related to worse survival (Table 4 and Figure 2(a)). There was no difference in early mortality between children and adults (21% vs. 36%; P=0.467) or according to the event happening before or after the year 2000 (30% vs. 31%, P=1.000). Outcome: late mortality For 25 survivors of SCD, 48 suitable age, disease and gender-matched controls were identified. For one patient, we were unable to identify a suitable matched control and this patient was therefore excluded from further analysis. This patient was an 8-year-old girl with mitral valve dysplasia and severe mitral valve regurgitation who survived after cardiac arrest due to ventricular fibrillation. She died 2 years later from sudden death. Survivors of SCD had a worse survival when compared to controls (5-year survival 76% vs. 98%; P=0.002) (Figure 2(b)). Discussion This study described patient and event characteristics of congenital heart disease patients requiring CPR. Overall,

Van Puyvelde et al. 5 Table 3. Event characteristics stratified to severity of congenital heart disease. Variable Total (n=38) Congenital heart disease severity P value Mild (n=4) Moderate (n=18) Severe (n=16) Initial rhythm, n (%) n=29 Shockable rhythm 23 (79) 2/3 (66) 12/14 (86) 9/12 (75) 0.541 Location, n (%) n=31 1.000 OHCA 21 (68) 1/3 (33) 5/14 (36) 4/14 (29) IHCA 10 (32) 2/3 (66) 9/14 (64) 10/14 (71) Ward 5/29 (17) Emergency room 4/29 (14) Operating room a 1/29 (3) Prehospital treatment in case of OHCA, n (%) n=21 ALS 18 (86) Bystander CPR 15 (71) None 1 (5) DC shock therapy, n (%) n=35 13 (37) Median number of DC shocks 3 (IQR 1 5) Cardiac therapy, n (%) n=29 18 (62) 0/3 (0) 11/15 (73) 7/11 (64) 0.085 Adrenaline 14/22 (64) Atropine 5/22 (23) Median ROSC time, minutes (IQR) 23 (15 34) 0.482 ICU admission, n (%) n=29 20 (69) 3/3 (100) 9/11 (81) 10/14 (71) Intubation, n (%) n=28 22 (79) 0.681 ECMO, n (%) n=30 2 (7) Tertiary care centre, n (%) n=27 12 (44) ICD implantation, n (%) n=36 12 (33) 1/4 (25) 7/16 (44) 4/16 (25) 0.545 a Non-cardiac surgery. VT: ventricular tachycardia; PEA: pulseless electrical activity; OHCA: out-of-hospital cardiac arrest; IHCA: inhospital cardiac arrest; CPR: cardiopulmonary resuscitation; ALS: advanced life support; DC: direct current; ROSC: return of spontaneous circulation; ICU: intensive care unit; ECMO: extracorporeal membrane oxygenation; ICD: implantable cardioverter defibrillator. Table 4. Factors related to early mortality in univariate binary logistic regression analysis. Variable OR (95%) P value Male gender 2.53 (0.45 14.37) 0.294 CHD complexity 5.17 (1.20 21.91) 0.027 Pulmonary hypertension 13.8 (2.13 89.52) 0.006 Tetralogy of Fallot 0.70 (0.12 4.20) 0.700 Univentricular heart 0.73 (0.07 7.95) 0.799 Age at event 1.02 (0.98 1.07) 0.341 SCD after year 2000 1.04 (0.21 5.08) 0.964 OHCA 2.46 (0.41 14.63) 0.322 Cardiac therapy 4.50 (0.46 44.29) 0.197 ROSC time 1.07 (1.00 1.12) 0.043 Need for intubation 0.75 (0.19 5.22) 0.771 VT/VF 4.67 (0.48 45.55) 0.185 CHD: congenital heart disease; SCD: sudden cardiac death; OHCA: outof-hospital cardiac arrest; ROSC: return of spontaneous circulation; VT: ventricular tachycardia; VF: ventricular fibrillation. early mortality was 34% and was mainly related to the severity of the underlying congenital heart disease, the presence of pulmonary hypertension and time to ROSC. Moreover, the long-term outcome of survivors of SCD is worse when compared to an age, gender and diseasematched control population. Patient and event characteristics The underlying congenital heart defects of patients who received CPR in this study were similar to previous reports on SCD in congenital heart disease, 2 with the majority of patients having moderate or severe congenital heart disease. Previous studies have identified risk factors for SCD in subpopulations such as ToF (age, number and type of surgeries, 4,11 QRS duration, 4,11 pulmonary regurgitation, 4 left ventricular dysfunction) 5 or patients with a systemic right ventricle (history of atrial arrhythmia, 6,12 systemic ventricular dysfunction/history of heart failure). 6,12,13 In patients with univentricular physiology, SCD accounts for 9% of late deaths 14 but no predictors have been identified. 2,14 Surprisingly, four patients who required CPR had underlying septal defect lesions in which ventricular arrhythmias would be considered uncommon. The majority of patients were men (66%). A male majority is often seen in SCD studies 15 22 and has been explained

6 European Heart Journal: Acute Cardiovascular Care decrease cardiac output and may eventually cause cardiac arrest. Primary ventricular arrhythmia is a possible, but rare, cause of SCD in patients with univentricular physiology. 14 Figure 2. (a) Kaplan Meier indicating survival in patients with congenital heart disease and cardiopulmonary resuscitation for sudden cardiac death (SCD) stratified according to the severity of the underlying congenital heart defect. Patients with severe complexity of underlying congenital heart disease had worse survival, which is mainly related to early mortality. When censoring the initial hospitalisation, there is no significant difference between the two groups (P=0.824 by log-rank test). (blue: mild/moderate complexity green: severe complexity). (b) Kaplan Meier indicating worse long-term event-free survival in survivors of SCD when compared to age, gender and diseasematched controls. (blue: survivors of SCD; green: age, gender and disease-matched controls). by an increased risk of ischaemia in men. 21 However, the male predominance in our study is explained by the high male-to-female ratio in patients with complex congenital heart disease (hypoplastic left heart syndrome, TGA and ToF) as compared to patients with mild congenital heart disease. 23 Our patients were also on average 30 40 years younger than patients included in resuscitation trials, 15,16,19 22 stressing the need to be aware of and look for risk factors associated with SCD, even at a young age. In those patients with rhythm documentation, 79% presented with a shockable rhythm, which is different from the general population. 16 22 It should be noted that supraventricular tachycardia in patients with TGA who underwent atrial rerouting (Mustard or Senning repair) or patients with univentricular physiology is not well tolerated as the absence of atria as a capacitance chamber, 24 or the absence of a subpulmonary ventricle 25 will limit ventricular filling, Early mortality Whereas previous reports primarily focused on the identification of predictors of SCD in patients with congenital heart disease, 2,4,5 to the best of our knowledge, this is the first study to evaluate the outcome of CPR in patients with structural heart defects. The main aim of CPR is to provide adequate stroke volume with chest compressions in order to maintain coronary perfusion, pulmonary blood flow and cerebral perfusion. In patients with underlying heart defects, the maintenance of stroke volume during CPR may be far more difficult and determinants of prognosis after CPR may be related to the complexity of the underlying heart defect. 26,27 Our data do indicate a relationship with the complexity of the underlying heart defect, which appears to be driven by the presence of pulmonary hypertension. A high pulmonary vascular resistance limiting adequate pulmonary blood flow and poor right ventricular coronary perfusion may explain the poor results of CPR in patients with pulmonary hypertension. This confirms a previous report evaluating CPR in patients with pulmonary arterial hypertension in which only six of 132 patients with pulmonary arterial hypertension in whom CPR was instituted survived more than 90 days. 28 Similarly, one may suggest that effective CPR is complicated in univentricular physiology because there is no equivalent for the atrioventricular valves to prevent retrograde flow to the caval system when the subpulmonary system is being compressed. However, there was no relationship between univentricular heart and outcome in our series. Nevertheless, it is surprising that, overall, early mortality was still lower when compared to data in the general population. 15 22 Presumably this is explained by a younger age, fewer comorbidities, and a higher proportion of shockable rhythms at the time of presentation in our population, all of which have been associated with better outcomes. 15,16,19 Other factors that may have contributed are awareness of the presence of an underlying heart defect, leading to early initiation of CPR either in hospital (with the patient being followed more closely) or out-of-hospital (with more awareness among family members). Although none of our patients had evidence of coronary artery disease, it is important that with an aging population, coronary artery disease should be considered. As worsening underlying haemodynamics may play a role, all patients should undergo careful haemodynamic evaluation. Late mortality In patients without structural heart defects, long-term survival after SCD is similar when compared to an age, gender

Van Puyvelde et al. 7 Table 5. Characteristics of patients who died after survival of initial cardiac arrest. Patient Original anatomy Cardiac arrest Cause of death Survival time 1. Male, 10 months Coarctation of the aorta, aortic stenosis Initial rhythm: unknown 2. Male, 17 years Double inlet left ventricle, transposition Initial rhythm: atrial of the great arteries, ventricular septal fibrillation defect, aortic stenosis 3. Female, 8 years Mitral insufficiency due to dysplastic Initial rhythm: mitral valve, pulmonary hypertension ventricular fibrillation 4. Male, 23 years Univentricular heart, tricuspid atresia, pulmonary stenosis, transposition of the great arteries, ventricular septal defect 5. Male, 40 years Perimembranous ventricular septal defect, right-sided aortic arch ICD: implantable cardioverter defibrillator. Initial rhythm: ventricular fibrillation Initial rhythm: ventricular fibrillation Unknown Postoperative orthotropic heart transplantation Sudden death, initial rhythm unknown Sudden death, initial rhythm unknown Sudden death, ICD failure (guidant vitality 2 VR (T175)) 662 days 2211 days 659 days 1106 days 3324 days and disease-matched control population. 9 In contrast, our study indicates that congenital heart disease patients have a worse prognosis after SCD when compared to an age, gender and disease-matched control population with a 5-year survival of 76% (versus 98% for matched controls). So, although the success rate of CPR may be higher, there is ongoing mortality after the index event. It could be that there is less reserve cardiac capacity to shoulder the damage attained after a cardiac arrest in congenital heart disease due to the degree of cardiac dysfunction already present. Moreover, sustained damage after cardiac arrest could stimulate arrhythmogenesis and therefore predispose for the recurrence of SCD. 29 Unfortunately, we had little information on the cause of death after discharge after cardiac arrest for the patients in our study (Table 5). Because of the abrupt nature of most deaths in our patients we can suspect that the recurrence of arrhythmia was a major contributor to late mortality. This information supports the consensus recommendation that ICD placement is indicated in secondary prevention for patients with congenital heart disease. 30 In our centre, every patient with congenital heart disease who had aborted SCD is evaluated to determine the exact cause of the event. An ICD in secondary prevention is implanted when no reversible cause for the event can be identified. In some patients, the event is a reflection of worsening haemodynamics and the occurrence of heart failure. Although implantation of an ICD will protect the patient from ventricular arrhythmias, it will not protect the patient from worsening heart failure. Therefore, close follow-up and timely consideration of advanced heart failure options is indicated. Limitations Our study has the following limitations. First, the study was based on retrospective registry data with the risk of missing data. Second, the study was a single-centre tertiary care study. This introduces the risk of referral bias with overrepresentation of complex congenital heart disease due to mild cases being handled in secondary care centres without them being referred to us. Although patient data in the database is regularly updated, there is a risk of selection bias as some patients with OHCA admitted to other hospitals are missed. Third, only data on survival after SCD were assessed and not on more advanced outcome measures so we cannot comment on the general state of patients after SCD. Fourth, we did not include patients without structural heart disease in the analysis. The database of Congenital and Structural Cardiology of the University Hospitals Leuven is maintained by the paediatric cardiology and adult congenital cardiology department. Adult patients without structural heart disease are not included in the database and therefore including patients without structural heart disease would have introduced a significant bias. Fifth, due to the relative rarity of SCD in congenital heart disease patients, our study population was small, which means a lack of power to demonstrate variables with a lower relative risk of early mortality. This also illustrates the need to create a larger, multicentre database on SCD in congenital heart disease in order to answer some of the emerging questions in this growing patient population. Conclusion The complexity of underlying heart defect, especially pulmonary hypertension and time to ROSC are related to worse outcomes in the case of CPR. Survivors of SCD have a worse outcome when compared to matched controls, indicating the need for adequate ICD indication assessment and for stringent follow-up of patients with worsening haemodynamics. Conflict of interest The authors declare that there are no conflicts of interest. Funding A Van De Bruaene is supported by a grant of the Frans van de Werf Fund for Clinical Cardiovascular Research, department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.

8 European Heart Journal: Acute Cardiovascular Care References 1. Moons P, Bovijn L, Budts W, et al. Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium. Circulation 2010; 122: 2264 2272. 2. Koyak Z, Harris L, de Groot JR, et al. Sudden cardiac death in adult congenital heart disease. Circulation 2012; 126: 1944 1954. 3. Verheugt CL, Uiterwaal CS, van der Velde ET, et al. Mortality in adult congenital heart disease. Eur Heart J 2010; 31: 1220 1229. 4. Gatzoulis MA, Balaji S, Webber SA, et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet 2000; 356: 975 981. 5. Ghai A, Silversides C, Harris L, et al. Left ventricular dysfunction is a risk factor for sudden cardiac death in adults late after repair of tetralogy of Fallot. J Am Coll Cardiol 2002; 40: 1675 1680. 6. Kammeraad JA, van Deurzen CH, Sreeram N, et al. Predictors of sudden cardiac death after Mustard or Senning repair for transposition of the great arteries. J Am Coll Cardiol 2004; 44: 1095 1102. 7. Merchant RM, Yang L, Becker LB, et al.; and American Heart Association. Get with the guidelines resuscitation I. Incidence of treated cardiac arrest in hospitalized patients in the United States. Crit Care Med 2011; 39: 2401 2406. 8. Sasson C, Rogers MA, Dahl J, et al. Predictors of survival from out-of-hospital cardiac arrest: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes 2010; 3: 63 81. 9. Bunch TJ, White RD, Gersh BJ, et al. Long-term outcomes of out-of-hospital cardiac arrest after successful early defibrillation. N Engl J Med 2003; 348: 2626 2633. 10. Warnes CA, Liberthson R, Danielson GK, et al. Task force 1: the changing profile of congenital heart disease in adult life. J Am Coll Cardiol 2001; 37: 1170 1175. 11. Khairy P, Aboulhosn J, Gurvitz MZ, et al.; and Alliance for Adult Research in Congenital Cardiology. Arrhythmia burden in adults with surgically repaired tetralogy of Fallot: a multi-institutional study. Circulation 2010; 122: 868 875. 12. Gatzoulis MA, Walters J, McLaughlin PR, et al. Late arrhythmia in adults with the mustard procedure for transposition of great arteries: a surrogate marker for right ventricular dysfunction? Heart 2000; 84: 409 415. 13. Koyak Z, de Groot JR, Van Gelder IC, et al. Implantable cardioverter defibrillator therapy in adults with congenital heart disease: who is at risk of shocks? Circ Arrhythm Electrophysiol 2012; 5: 101 110. 14. Khairy P, Fernandes SM, Mayer JE, Jr., et al. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation 2008; 117: 85 92. 15. Wibrandt I, Norsted K, Schmidt H, et al. Predictors for outcome among cardiac arrest patients: the importance of initial cardiac arrest rhythm versus time to return of spontaneous circulation, a retrospective cohort study. BMC Emerg Med 2015; 15: 3. 16. Fukuda T, Matsubara T, Doi K, et al. Predictors of favorable and poor prognosis in unwitnessed out-of-hospital cardiac arrest with a non-shockable initial rhythm. Int J Cardiol 2014; 176: 910 915. 17. Meyer L, Stubbs B, Fahrenbruch C, et al. Incidence, causes, and survival trends from cardiovascular-related sudden cardiac arrest in children and young adults 0 to 35 years of age: a 30-year review. Circulation 2012; 126: 1363 1372. 18. Deasy C, Bray JE, Smith K, et al. Out-of-hospital cardiac arrests in young adults in Melbourne, Australia adding coronial data to a cardiac arrest registry. Resuscitation 2011; 82: 1302 1306. 19. Herlitz J, Svensson L, Engdahl J, et al. Characteristics of cardiac arrest and resuscitation by age group: an analysis from the Swedish Cardiac Arrest Registry. Am J Emerg Med 2007; 25: 1025 1031. 20. Meaney PA, Nadkarni VM, Kern KB, et al. Rhythms and outcomes of adult in-hospital cardiac arrest. Crit Care Med 2010; 38: 101 108. 21. Bougouin W, Lamhaut L, Marijon E, et al. Characteristics and prognosis of sudden cardiac death in Greater Paris: population-based approach from the Paris Sudden Death Expertise Center (Paris-SDEC). Intens Care Med 2014; 40: 846 854. 22. Nielsen N, Wetterslev J, Cronberg T, et al. Targeted temperature management at 33 degrees C versus 36 degrees C after cardiac arrest. N Engl J Med 2013; 369: 2197 2206. 23. Hoffman JI and Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002; 39: 1890 1900. 24. Derrick GP, Narang I, White PA, et al. Failure of stroke volume augmentation during exercise and dobutamine stress is unrelated to load-independent indexes of right ventricular performance after the Mustard operation. Circulation 2000; 102: III154 III159. 25. La Gerche A and Gewillig M. What limits cardiac performance during exercise in normal subjects and in healthy Fontan patients? Int J Pediatr 2010; 2010: 791291. 26. Kleinman ME, Brennan EE, Goldberger ZD, et al. Part 5: Adult basic life support and cardiopulmonary resuscitation quality: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2015; 132: S414 S435. 27. de Caen AR, Berg MD, Chameides L, et al. Part 12: Pediatric advanced life support: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2015; 132: S526 S542. 28. Hoeper MM, Galie N, Murali S, et al. Outcome after cardiopulmonary resuscitation in patients with pulmonary arterial hypertension. Am J Respir Crit Care Med 2002; 165: 341 344. 29. Escudero C, Khairy P and Sanatani S. Electrophysiologic considerations in congenital heart disease and their relationship to heart failure. Can J Cardiol 2013; 29: 821 829. 30. Khairy P, Van Hare GF, Balaji S, et al. PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Can J Cardiol 2014; 30: e1 e63.